Qinghai Gelatin to Sell TCM Subsidiary to Chongqing Lummy Pharma

Qinghai Gelatin has reached a framework agreement to sell its drug making subsidiary, Sichuan Hezheng Pharmaceutical, to Chongqing Lummy Pharmaceutical for 90 million RMB ($13.5 million). Hezheng Pharma produces TCM products in the form of pills, granules, capsules, tablets, and non-food health products.  More details.... Stock Symbols: (SHEX: 000606) (SHEX: 300006)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.